FigsharePub Date : 2024-08-01DOI: 10.1021/acsnano.4c04024.s001
Haibin Lu (3153807), Weifang Tong (2070619), Meixu Jiang (12870765), Huimin Liu (284624), Chen Meng (411751), Kai Wang (21246), Xupeng Mu (5811020)
{"title":"Mitochondria-TargetednMultifunctional Nanoprodrugsnby Inhibiting Metabolic Reprogramming for Combating Cisplatin-ResistantnLung Cancer","authors":"Haibin Lu (3153807), Weifang Tong (2070619), Meixu Jiang (12870765), Huimin Liu (284624), Chen Meng (411751), Kai Wang (21246), Xupeng Mu (5811020)","doi":"10.1021/acsnano.4c04024.s001","DOIUrl":"https://doi.org/10.1021/acsnano.4c04024.s001","url":null,"abstract":"How to address the resistance ofncisplatin (CDDP) has always beenna clinical challenge. The resistance mechanism of platinum-based drugsnis very complex, including nuclear DNA damage repair, apoptosis escape,nand tumor metabolism reprogramming. Tumor cells can switch betweennmitochondrial oxidative phosphorylation (OXPHOS) and glycolysis andndevelop resistance to chemotherapy drugs through metabolic variability.nIn addition, due to the lack of histone protection and a relativelynweak damage repair ability, mitochondrial DNA (mtDNA) is more susceptiblento damage, which in turn affects mitochondrial OXPHOS and can becomena potential target for platinum-based drugs. Therefore, mitochondria,nas targets of anticancer drugs, have become a hot topic in tumor resistancenresearch. This study constructed a self-assembled nanotargeted drugndelivery system LND-SS-Pt-TPP/HA-CD. β-Cyclodextrin-graftednhydronic acid (HA-CD)-encapsulated prodrug nanoparticles can targetnCD44 on the tumor surface and further deliver the prodrug to intracellularnmitochondria through a triphenylphosphine group (TPP<sup>+</sup>).nDisulfide bonds can be selectively degraded by glutathione (GSH) innmitochondria, releasing lonidamine (LND) and the cisplatin prodrugn(Pt(IV)). Under the action of GSH and ascorbic acid, Pt(IV) is furthernreduced to cisplatin (Pt(II)). Cisplatin can cause mtDNA damage, inducenmitochondrial dysfunction and mitophagy, and then affect mitochondrialnOXPHOS. Meanwhile, LND can reduce the hexokinase II (HK II) level,ninduce destruction of mitochondria, and block energy supply by glycolysisninhibition. Ultimately, this self-assembled nano targeted deliverynsystem can synergistically kill cisplatin-resistant lung cancer cells,nwhich supplies an overcome cisplatin resistance choice via the disruptnmitochondria therapy.","PeriodicalId":521671,"journal":{"name":"Figshare","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147883616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}